Addvise logo
sv_SE
sv_SE
search

Invitation to presentation of interim report April 1 – June 30, 2023

06-07-2023   Non-regulatory press release

Stockholm, July 6, 2023

Invitation to presentation of interim report April 1 – June 30, 2023

 

Media, investors and analysts are on the same day invited to attend a presentation of the interim report April 1 – June 30, 2023 at July 20 13:00 (CEST), 07:00 AM (EST). The CEO, Rikard Akhtarzand, will present the report in a webcast and telephone conference.

 

Webcast

If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.

https://ir.financialhearings.com/addvise-group-q2-2023/register

 

Conference call

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

https://conference.financialhearings.com/teleconference/?id=5005449

 

The report, presentation material and a link to the webcast will be available on

https://www.addvisegroup.com/investor-relations/

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

About ADDvise Group


ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise Group’s CEO divests shares - remains a committed and long-term shareholder

Regulatory

Rikard Akhtarzand, CEO of ADDvise Group AB (publ) (“ADDvise” or the “Company”), has informed the Company that he has sold 2,500,000 Class B shares in ADDvise, representing approximately 1.3% of total outstanding shares and 18.1% of his total shareholding in the Company, and that he has entered a 180-day lock-up agreement for his remaining shares.…

ADDvise acquires Diabetic Supplies Inc.

Regulatory

ADDvise Group has today entered into a share purchase agreement with the owners of Diabetic Supplies Inc. (“Diabetic Supplies”) regarding the acquisition of all shares of Diabetic Supplies in accordance with the letter of intent previously communicated. Closing of the acquisition is expected to take place at the beginning of September 2023. Diabetic Supplies’ revenue…

ADDvise receives order worth USD 4 million

Regulatory

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Tecnimont. The order involves the design endorsement, supply, and installation of multiple cleanroom facilities as part of a larger industrial project. The order is worth approximately USD 4 million. Tecnimont, a subsidiary of Maire, is a leading integrated engineering and construction services and…

ADDvise Group recruits Oliver Humlen as new CFO

Regulatory

ADDvise recruits Oliver Humlen as new CFO and member of the executive management team. Oliver has more than a decade of experience from investment banking. He joins ADDvise from Pareto Securities where he has been working within Debt Capital Markets for the past nine years, of which six as Partner. Prior to that, he worked…